ANKET ® ( A ntibody-based NK cell E ngager T herapeutics) is Innate's proprietary platform for developing next-generation, multi-specific natural killer (NK) cell engagers to treat certain types of ...
Results from a new animal study found that maternal exposure to e-cigarette residues, with or without nicotine, affected ...
LIfT BioSciences, a rapidly emerging biotech company preparing to start clinical trials for its first-in-class allogeneic innate cell therapy ... to give a durable response and long-lasting ...
Vir Biotechnology, Inc. today announced positive results from the SOLSTICE Phase 2 clinical trial evaluating tobevibart alone, or in combination with elebsiran, in people with chronic hepatitis delta ...
Instead, their decentralised nature ensures immunity from conventional regulatory frameworks ... despite potential risks ...
It appears that the fungus allows the Ork’s body to negate the use of complex internal organs, the immune system, and the ...
Supplements like vitamin C and zinc may lessen the severity or duration of cold symptoms should you get sick this winter, ...
A Golden Gate-based dual-expression vector enables rapid screening, which facilitates efficient isolation of high-affinity cross-reactive antibodies for therapeutic or diagnostic use and provides a ...